Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Revenue (2022 - 2025)

Envoy Medical's Revenue history spans 4 years, with the latest figure at $42000.0 for Q3 2025.

  • For Q3 2025, Revenue fell 25.0% year-over-year to $42000.0; the TTM value through Sep 2025 reached $208000.0, down 25.18%, while the annual FY2024 figure was $225000.0, 28.8% down from the prior year.
  • Revenue for Q3 2025 was $42000.0 at Envoy Medical, down from $78000.0 in the prior quarter.
  • Across five years, Revenue topped out at $95000.0 in Q4 2023 and bottomed at $20000.0 in Q4 2022.
  • The 4-year median for Revenue is $59000.0 (2024), against an average of $60307.7.
  • The largest annual shift saw Revenue soared 375.0% in 2023 before it plummeted 55.79% in 2024.
  • A 4-year view of Revenue shows it stood at $20000.0 in 2022, then skyrocketed by 375.0% to $95000.0 in 2023, then tumbled by 55.79% to $42000.0 in 2024, then changed by 0.0% to $42000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Revenue are $42000.0 (Q3 2025), $78000.0 (Q2 2025), and $46000.0 (Q1 2025).